Prim-O-glucosylcimifugin suppresses M2 macrophage polarization via the JAK2-STAT6-PPARγ pathway to alleviate allergic asthma

Background: Allergic asthma (AA) is a chronic respiratory disease closely linked to immune-inflammatory responses driven by M2 macrophage polarization. PrimO-glucosylcimifugin (POG), a natural bioactive compound from Saposhnikovia divaricata (SD), alleviates inflammation in acute lung injury mice, but whether it mitigates AA by modulating M2 macrophage polarization remains unclear. Objective: This study investigated POG’s effects on AA and its mechanisms in regulating M2 macrophage polarization. Methods: LC-MS profiled the SD/Prunus mume (PM) combination, and network pharmacology predicted its main active components and key anti-AA mechanisms. Ovalbumin (OVA) plus IL-4 established AA models in mice and RAW264.7 cells. Lung protection was assessed by histopathology, lung indices, and type II immune inflammatory cytokine markers. Flow Cytometry, RT-qPCR, immunofluorescence, and Western blot examined key genes/proteins in the JAK2-STAT6-PPARγ axis. Results: LC-MS-based network pharmacology identified POG as the key SD/PM active ingredient alleviating AA. Pharmacodynamic evaluation showed POG effectively alleviated OVA-induced airway inflammation and pulmonary histopathological damage in AA mice. Mechanistically, POG inhibited M2 macrophage polarization by downregulating key JAK2-STAT6-PPARγ axis factors. Conclusion: POG ameliorates AA by reducing type II immune factor release through JAK2-STAT6-PPARγ-mediated inhibition of M2 macrophage polarization. This study clarifies POG’s anti-AA mechanism and supports its clinical development.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-17
DOI
https://doi.org/10.64898/2026.11.10.765782
Primary Topic
Asthma and respiratory diseases
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Prim-O-glucosylcimifugin suppresses M2 macrophage polarization via the JAK2-STAT6-PPARγ pathway to alleviate allergic asthma

Hong Zhang, Honghong Huang, Chong Li, Weiwei Yang et al.
1 links
bioRxiv (Cold Spring Harbor Laboratory)
Asthma and respiratory diseases
preprint

Prim-O-glucosylcimifugin suppresses M2 macrophage polarization via the JAK2-STAT6-PPARγ pathway to alleviate allergic asthma

Hong Zhang, Honghong Huang, Chong Li, Weiwei Yang, Haiyan Fu
preprint en

Abstract

Background: Allergic asthma (AA) is a chronic respiratory disease closely linked to immune-inflammatory responses driven by M2 macrophage polarization. PrimO-glucosylcimifugin (POG), a natural bioactive compound from Saposhnikovia divaricata (SD), alleviates inflammation in acute lung injury mice, but whether it mitigates AA by modulating M2 macrophage polarization remains unclear. Objective: This study investigated POG’s effects on AA and its mechanisms in regulating M2 macrophage polarization. Methods: LC-MS profiled the SD/Prunus mume (PM) combination, and network pharmacology predicted its main active components and key anti-AA mechanisms. Ovalbumin (OVA) plus IL-4 established AA models in mice and RAW264.7 cells. Lung protection was assessed by histopathology, lung indices, and type II immune inflammatory cytokine markers. Flow Cytometry, RT-qPCR, immunofluorescence, and Western blot examined key genes/proteins in the JAK2-STAT6-PPARγ axis. Results: LC-MS-based network pharmacology identified POG as the key SD/PM active ingredient alleviating AA. Pharmacodynamic evaluation showed POG effectively alleviated OVA-induced airway inflammation and pulmonary histopathological damage in AA mice. Mechanistically, POG inhibited M2 macrophage polarization by downregulating key JAK2-STAT6-PPARγ axis factors. Conclusion: POG ameliorates AA by reducing type II immune factor release through JAK2-STAT6-PPARγ-mediated inhibition of M2 macrophage polarization. This study clarifies POG’s anti-AA mechanism and supports its clinical development.

bioRxiv (Cold Spring Harbor Laboratory)
Chengdu University (CN), CM Hospital (KR), Hainan Provincial Hospital of Traditional Chinese Medicine (CN), Second Affiliated Hospital of Chengdu University of Traditional Chinese (CN), Chengdu University of Traditional Chinese Medicine (CN)
National Natural Science Foundation of China, Hainan Provincial Department of Science and Technology
Good health and well-being
Asthma and respiratory diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon